Relationship Between Serum ET-1, HDL-C, and sVCAM-1 and Hearing Loss in Patients with Sudden Deafness

• Published in: Applied biochemistry and biotechnology Vol. 196; no. 3; pp. 1376 - 1385
• Main Authors: Wang, Zhao Hua, Zhang, Hai Li
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.03.2024; Springer Nature B.V
• Subjects: Biochemistry; Biotechnology; blood serum; Cell adhesion; Cell adhesion molecules; Chemistry; Chemistry and Materials Science; China; Cholesterol; Cholesterol, HDL; Deafness; Diagnostic systems; Endothelin 1; endothelins; Enzyme-linked immunosorbent assay; gender; Hearing loss; Hearing Loss, Sensorineural - complications; Hearing Loss, Sensorineural - diagnosis; Hearing Loss, Sudden - complications; Hearing Loss, Sudden - diagnosis; Hearing protection; High density lipoprotein; high density lipoprotein cholesterol; hospitals; Humans; Original Article; Patients; Prognosis; Serum levels; Vascular cell adhesion molecule 1; vascular cell adhesion molecules; China; HDL-C; Diagnostic value; ET-1; Prognosis; Degree of hearing loss; sVCAM-1; Sudden deafness
• DOI: 10.1007/s12010-023-04593-9
• ISSN: 0273-2289; 1559-0291

Vascular causes are most commonly associated with sudden sensorineural hearing loss (SSHL). This study was performed to determine the relationship between serum endothelin-1 (ET-1), high-density lipoprotein cholesterol (HDL-C), soluble vascular cell adhesion molecule-1 (sVCAM-1) levels, and the degree of hearing loss in patients with SSHL. Firstly, 60 SSHL patients were admitted to The First Hospital of Shanxi Medical University. In the same period, 60 healthy subjects matching the age and gender of SSHL patients were selected as the control group. Then, serum levels of ET-1, HDL-C, and sVCAM-1 were measured by enzyme-linked immunosorbent assay (ELISA). Next, the relationship between serum levels of ET-1, HDL-C, and sVCAM-1 with clinicopathological factors and their diagnostic and prognostic values were analyzed and evaluated. Serum ET-1 and sVCAM-1 were increased, and HDL-C was decreased in patients with SSHL. Serum ET-1 and sVCAM-1 were higher and HDL-C was lower in patients aged ≥ 45 years, or severe hearing loss patients ( P  < 0.05). ROC analysis determined that ET-1 (AUC = 0.839), HDL-C (AUC = 0.830), and sVCAM-1 (AUC = 0.865) had excellent diagnostic values. In addition, patients with low levels of ET-1 and sVCAM-1 and high levels of HDL-C had better hearing prognosis ( P  < 0.05). Abnormal serum ET-1, HDL-C, and sVCAM-1 in patients with SSHL are closely related to age, and degree of hearing loss, and perform diagnostic and prognostic values.